BioPharma Company, CEO Hit With Investor Class Action Lawsuit

(June 29, 2021, 1:00 PM EDT) -- SEATTLE — Two shareholders of a pharmaceutical company that develops certain treatments for neurological diseases sued the company and its CEO in Washington federal court on June 25, alleging that the...
To view the full article, register now.